Fosaprepitant and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Fosaprepitant (fosaprepitant), especially for people who are female, 40-49 old, also take Stelara, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Ipf when taking Fosaprepitant. It is created by eHealthMe based on reports of 1,178 people who have side effects when taking Fosaprepitant from the FDA, and is updated regularly.

What is Fosaprepitant?

Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.

What is Ipf?

Ipf is found to be associated with 1,792 drugs and 2,276 conditions by eHealthMe. Check the latest studies of Ipf.

On Jun, 06, 2026

1,178 people reported to have side effects when taking Fosaprepitant.
Among them, 14 people (1.19%) have Ipf.

Among these 14 people:

What is the gender of people who have Ipf when taking Fosaprepitant? *

female: 100 %
male: 0.0 %

What is the age of people who have Ipf when taking Fosaprepitant? *

What are other drugs people take besides Fosaprepitant? *

Acetaminophen: 14 people, 100.00%
Simponi: 14 people, 100.00%
Naproxen Sodium: 14 people, 100.00%
Celebrex: 14 people, 100.00%
Cetirizine Hydrochloride: 14 people, 100.00%
Cosentyx: 14 people, 100.00%
Diclofenac Sodium: 14 people, 100.00%
Otezla: 14 people, 100.00%
Prednisone: 14 people, 100.00%
Stelara: 14 people, 100.00%

What are other side effects people have besides Ipf? *

Dizziness: 14 people, 100.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 14 people, 100.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 100.00%
Dry Mouth: 13 people, 92.86%
Facet Joint Syndrome (problem with movement of the facet joints of the spine): 13 people, 92.86%
Drug Hypersensitivity: 13 people, 92.86%
Joint Range Of Motion Decreased (disease of joint movement): 13 people, 92.86%
High Blood Pressure: 12 people, 85.71%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 12 people, 85.71%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 12 people, 85.71%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 14 people, 100.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 11 people, 78.57%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 64.29%
Joint Pain: 6 people, 42.86%
Headache (pain in head): 4 people, 28.57%
Migraine (headache): 2 people, 14.29%
Inflammation: 2 people, 14.29%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Fosaprepitant and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fosaprepitant:

Fosaprepitant (1,178 reports)

Ipf treatments and more:

Ipf (79,194 reports)

Browse all side effects of Fosaprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,792 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,276 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosaprepitant (the active ingredients of Fosaprepitant) and Fosaprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.